Angiotensin converting enzyme inhibitors or angiotensin receptor blockers: evidence for their effects on mortality and major cardiovascular events in hypertensive diabetics. Portuguese Journal of Family Medicine and General Practice, [S. l.], v. 32, n. 5, p. 330–38, 2016. DOI: 10.32385/rpmgf.v32i5.11887. Disponível em: https://rpmgf.pt/ojs/index.php/rpmgf/article/view/11887. Acesso em: 18 apr. 2026.